A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma

Yaoting Li(Guangxi Medical University), Xuezhen Zeng(Sun Yat-sen University)

Frontiers in Pharmacology

January 10, 2023

10.3389/fphar.2022.1081952

Cited by 20

Related Papers

Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation

|Hepatology|2022|164

Targeting tumour-intrinsic N <sup>7</sup> -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy

|Gut|2022|79

Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma

|Cancer Immunology Research|2022|72

Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences

|Gut|2023|66